home | sitemap | feedback





Run by S.R. Trust

Radiation Oncology

Cancer is characterized by uncontrolled growth, and the ability to infiltrate surrounding tissues and spread to distant sites. The clinical manifestations of malignancy depend in part on the innate potential of the growth, but also on host factors, anatomical, metabolic and immunological, which may encourage or inhibit the neoplastic process. The resulting spectrum of malignancy extends from tumours which may stay unchanged for several years, very rarely metasta size and which may have no impact on life expectancy, to tumours which may kill within days of the first indication of their presence.

Most cancers arise from a mutation in a single cell and therefore represent a monoclonal population, but some growths are polyclonal, indicating that they have developed following more than one mutation.


Facilities & Equipment

Doctors

Amarnath. G 
MBBS.,DMRT.,MBA., 
Sr.Consultant

By the year 2010 eight million newly diagnosed cancer patients will be seen in developing countries as compared to five million patients in the developed countries.

The crude incidence rate of cancer in India is 44 to 96 per 1,00,000 population. A global comparison shows that India has high incidence rates of cancers of the uterine cervix & head and neck.

The etiology of malignancy is multifactorial ranging from diet, life style genetics, radiation, chemicals etc. Cancer is considered to be the final result of interplay of several factors or stimulus. It is likely that there has been a shift in the etiological factors and mechanism of carcinogenesis due to change in life styles with time.

The last two decades have witnessed considerable advances in the treatment of cancer, with cure now being a realistic therapeutic objective in over 50% of newly diagnosed patients.

Radiation therapy has been extraordinarily exciting in the past few years. Development in conforming the high dose radiation to the tumour with advanced techniques for planning plus evidence supporting the integration of cytotoxic chemotherapy and hormones with radiation therapy are widely available. The availability and potential use of molecular therapeutics are also on the horizon.


© 2006-2007 Meenakshi Mission Hospital and Research Centre. All rights reserved.

This site is hosted by Dot Com Infoway